Parp inhibitor containing piperazine structure, preparation method therefor and pharmaceutical use thereof
US-2024336624-A1 · Oct 10, 2024 · US
Injectable combination of adrenergic receptor agonists with fillers, for decreasing skin reactions due to injection
US9050246B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9050246-B2 |
| Application number | US-201013322803-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 28, 2010 |
| Priority date | May 29, 2009 |
| Publication date | Jun 9, 2015 |
| Grant date | Jun 9, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention concerns an injectable composition comprising a filler or a botulinum toxin and an adrenergic receptor agonist, and its use for diminishing, decreasing or avoiding skin reactions due to injection, specially redness, ecchymosis, bruising, bleeding, erythema, oedema, necrosis, ulceration, swelling and/or inflammation.
First claim
Opening claim text (preview).
The invention claimed is: 1. An injectable composition for treating a skin defect comprising: i. hyaluronic acid (HA); ii. an α-adrenergic receptor agonist; and iii. an anaesthetic, wherein the anaesthetic is lidocaine or a pharmaceutically acceptable salt thereof. 2. The composition of claim 1 , wherein the α-adrenergic receptor agonist is an α2-adrenergic receptor agonist. 3. The composition of claim 1 , wherein the composition com…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9050246B2 cover?
- The present invention concerns an injectable composition comprising a filler or a botulinum toxin and an adrenergic receptor agonist, and its use for diminishing, decreasing or avoiding skin reactions due to injection, specially redness, ecchymosis, bruising, bleeding, erythema, oedema, necrosis, ulceration, swelling and/or inflammation.
- Who is the assignee on this patent?
- Bertholon Isabelle, Brunel Florence, Herbage Benjamin, and 2 more
- What technology area does this patent fall under?
- Primary CPC classification A61K31/498. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Jun 09 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).